Posted by: admin on: May 31, 2011
The American College of Cardiology and the American Heart Association have issued the first guidance specifically for the treatment of hypertension in patients 65 and older in the form of an expert consensus document.
In general, the target blood pressure should be less than 140/90 mm Hg, although the authors acknowledged that there was some uncertainty about whether patients 80 and older should have a different goal than those ages 65 to 79.
Posted by: admin on: May 30, 2011
WASHINGTON — The FDA said it was concerned about trial data suggesting that adding a fibrate drug to a statin increased the risk of cardiac events in women and will convene an advisory committee meeting next month to review the findings.
The agency was reacting to a new analysis of the ACCORD-Lipid trial, which tested the addition of delayed-release fenofibric acid (Trilipix) to simvastatin (Zocor) in diabetic patients.
Main results from the trial, announced in March 2010, indicated that the combination did not reduce cardiovascular events relative to patients receiving only the statin drug.
Read more: http://www.medpagetoday.com/Cardiology/Dyslipidemia/26133
Posted by: admin on: May 30, 2011
Exercise is being emphasized as a preventive medicine option at Saginaw Valley State University as the school joins a new initiative with Exercise is Medicine.
“This is a new initiative that we’re looking to incorporate into our wellness program,” said Cynthia Bala, associate director of human resources at SVSU. “It’s taking our wellness program to that next step.”
Posted by: admin on: May 27, 2011
Mirroring findings in younger adults, a new study of adults 75 years and older at baseline suggests that drinking light to moderate amounts of alcohol may help protect against the development of dementia.
Posted by: admin on: May 27, 2011
February 14, 2011 – According to online results of an observational study reported in the Archives of Internal Medicine, “Concurrent use of proton pump inhibitors (PPIs) is associated with a dose-dependent loss of protection against hip fracture with alendronate in elderly patients.”